Ascentage Pharma Group Corporation Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Pharma
Founded:2009
Lead Investor(s):N/A
Press
Claim your profile

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Ascentage Pharma Group Corporation's estimated annual revenue is currently $17.1M per year.
  • Ascentage Pharma Group Corporation's estimated revenue per employee is $201,000

Employee Data

  • Ascentage Pharma Group Corporation has 85 Employees.
  • Ascentage Pharma Group Corporation grew their employee count by 29% last year.
  • Ascentage Pharma Group Corporation currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Advarra
$52.1M25929%N/A
Correct Rx Phar...
$16.5M82-6%N/A
ISPE
$78.4M390N/AN/A
Factor One Sour...
$7.2M3629%N/A
Ascentage Pharm...
$17.1M8529%N/A
United Therapeu...
N/A806N/AN/A
Pharmaceutics I...
$51.5M256N/AN/A
SilcsBio
$1M5N/AN/A
India Globaliza...
N/A12N/AN/A
Rexahn Pharmace...
N/A15N/AN/A
Missing a competitor? Contribute!?
Submit

Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company's expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com.

keywords:N/A

85

Number of Employees

$17.1M

Revenue (est)

1

Current Jobs

29%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Caroline ZhangManager, Ipo And Bd
Jason GilmoreDirector of Human ResourcesEmail Available
Robin MulveyProject ManagerEmail Available
Piyush SheladiaSr. Project ManagerEmail Available
Cindy CaoVice President, Head of Regulatory Affairs
Ying ZhangAssociate Director,data Management, Clinical DevelopmentEmail Available
Siobhan SolomonOffice Manager and Meeting/Event Planner with over 30 years experienceEmail Available
Tom KnappSVP, General Counsel
Jeff KmetzChief Business OfficerEmail Available
Dajun YangCo-Founder, Chairman & Chief Executive OfficerEmail Available

Ascentage Pharma Group Corporation News

08/26/2019 - Global Bcl-2-Like Protein 1 Market Growth, Analysis, Demand ...

Global Bcl-2-Like Protein 1 Market Growth, Analysis, Demand & Forecast 2019-2026: AbbVie Inc, Ascentage Pharma Group Corp Ltd.

08/15/2019 - Global Bcl-2-Like Protein 1 Market Analysis, Size, Share ...

Global Bcl-2-Like Protein 1 Market Analysis, Size, Share, Demand & Forecast 2019-2026: AbbVie Inc, Ascentage Pharma Group Corp Ltd.

08/09/2019 - Global Bcl-2-Like Protein 1 Market 2019 by Major Players ...

Top Key Players profiled in this report: AbbVie Inc, Ascentage Pharma Group Corp Ltd, Takeda Pharmaceutical Company Limited. Get FREE ...

Ascentage Pharma Group Corporation Executive Hires

DateNameTitleReference
2019-02-15Jeff KmetzChief Business OfficerArticle
2019-03-19Thomas KnappSVP, General CounselArticle